Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27-63. https://doi.org/10.1007/s12022-022-09707-3.

Article  PubMed  Google Scholar 

Mete O, Boucher A, Schrader KA, Abdel-Rahman O, Bahig H, Ho C, et al. Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. Endocr Pathol. 2024;35(4):293-308. https://doi.org/10.1007/s12022-024-09836-x.

Article  PubMed  PubMed Central  Google Scholar 

Wan SK, Chan JK, Tang SK. Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel’s thyroiditis. Am J Clin Pathol. 1996;105(4):388-93. https://doi.org/10.1093/ajcp/105.4.388.

Article  CAS  PubMed  Google Scholar 

Carda C, Ferrer J, Vilanova M, Peydro A, Llombart-Bosch A. Anaplastic carcinoma of the thyroid with rhabdomyosarcomatous differentiation: a report of two cases. Virchows Arch. 2005;446(1):46-51. https://doi.org/10.1007/s00428-004-1123-0.

Article  PubMed  Google Scholar 

Deeken-Draisey A, Yang GY, Gao J, Alexiev BA. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol. 2018;82:140-8. https://doi.org/10.1016/j.humpath.2018.07.027.

Article  CAS  PubMed  Google Scholar 

Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach. Endocrinol Metab (Seoul). 2022;37(5):703-18. https://doi.org/10.3803/EnM.2022.1553.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bishop JA, Sharma R, Westra WH. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. Hum Pathol. 2011;42(12):1873-7. https://doi.org/10.1016/j.humpath.2011.02.004.

Article  CAS  PubMed  Google Scholar 

Suzuki A, Hirokawa M, Takada N, Higuchi M, Yamao N, Kuma S, et al. Diagnostic significance of PAX8 in thyroid squamous cell carcinoma. Endocr J. 2015;62(11):991-5. https://doi.org/10.1507/endocrj.EJ15-0226.

Article  CAS  PubMed  Google Scholar 

Lai WA, Hang JF, Liu CY, Bai Y, Liu Z, Gu H, et al. PAX8 expression in anaplastic thyroid carcinoma is less than those reported in early studies: a multi-institutional study of 182 cases using the monoclonal antibody MRQ-50. Virchows Arch. 2020;476(3):431-7. https://doi.org/10.1007/s00428-019-02708-4.

Article  CAS  PubMed  Google Scholar 

Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg. 2000;231(3):329-38. https://doi.org/10.1097/00000658-200003000-00005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao SN, Zafereo M, Dadu R, Busaidy NL, Hess K, Cote GJ, et al. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid. 2017;27(5):672-81. https://doi.org/10.1089/thy.2016.0395.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, et al. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases. Thyroid. 2020;30(10):1505-17. https://doi.org/10.1089/thy.2020.0086.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agarwal S, Bychkov A, Jung CK. Emerging Biomarkers in Thyroid Practice and Research. Cancers (Basel). 2021;14(1). https://doi.org/10.3390/cancers14010204.

Merritt CR, Ong GT, Church SE, Barker K, Danaher P, Geiss G, et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38(5):586-99. https://doi.org/10.1038/s41587-020-0472-9.

Article  CAS  PubMed  Google Scholar 

Agarwal S, Jung CK, Gaddam P, Hirokawa M, Higashiyama T, Hang JF, et al. PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma: A Multi-institutional Study. Am J Surg Pathol. 2024;48(10):1233-44. https://doi.org/10.1097/PAS.0000000000002284.

Article  PubMed  Google Scholar 

Oh SE, Oh MY, An JY, Lee JH, Sohn TS, Bae JM, et al. Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer. Pathol Oncol Res. 2021;27:1609860. https://doi.org/10.3389/pore.2021.1609860.

Article  PubMed  PubMed Central  Google Scholar 

Ding C, Yu Z, Li X, Zhu J, Dai M, He Q. Collagen type VII alpha1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer. Oncol Lett. 2023;25(2):77. https://doi.org/10.3892/ol.2023.13663.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khoei SG, Sadeghi H, Samadi P, Najafi R, Saidijam M. Relationship between Sphk1/S1P and microRNAs in human cancers. Biotechnol Appl Biochem. 2020;68(2):279-87. https://doi.org/10.1002/bab.1922.

Article  CAS  PubMed  Google Scholar 

Liang W, Xie Z, Cui W, Guo Y, Xu L, Wu J, et al. Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer. J Cancer Res Clin Oncol. 2017;143(4):601-11. https://doi.org/10.1007/s00432-016-2315-0.

Article  CAS  PubMed  Google Scholar 

Zhao Z, Ma J, Hu B, Zhang Y, Wang S. SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway. Exp Ther Med. 2018;15(6):5007-16. https://doi.org/10.3892/etm.2018.6054.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu T, Liu JX, Xie J, Gao Z, Yang Z. LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis. BMJ Open. 2022;12(11):e063682. https://doi.org/10.1136/bmjopen-2022-063682.

Article  PubMed  PubMed Central  Google Scholar 

Garg M, Kanojia D, Okamoto R, Jain S, Madan V, Chien W, et al. Laminin-5gamma-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR. J Clin Endocrinol Metab. 2014;99(1):E62-72. https://doi.org/10.1210/jc.2013-2994.

Article  PubMed  Google Scholar 

Liu K, Fan J, Wu J. Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin alphavbeta3/focal adhesion kinase pathways. Drug Discov Ther. 2017;11(4):212-7. https://doi.org/10.5582/ddt.2017.01017.

Article  CAS  PubMed  Google Scholar 

Guo H, Liu R, Wu J, Li S, Yao W, Xu J, et al. SRPX2 promotes cancer cell proliferation and migration of papillary thyroid cancer. Clin Exp Med. 2023;23(8):4825-34. https://doi.org/10.1007/s10238-023-01113-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Zhu G, Yang L, Yang Y. Targeting CD24 as a novel immunotherapy for solid cancers. Cell Communication and Signaling. 2023;21(1). https://doi.org/10.1186/s12964-023-01315-w.

Han SA, Jang JH, Won KY, Lim SJ, Song JY. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma. Pathol Res Pract. 2017;213(8):956-63. https://doi.org/10.1016/j.prp.2017.05.002.

Article  CAS  PubMed  Google Scholar 

Zhang L, Zhou M, Gao X, Xie Y, Xiao J, Liu T, et al. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity. BMC Cancer. 2023;23(1):1048. https://doi.org/10.1186/s12885-023-11556-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Václavíková R, Hughes DJ, Souček P. Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease. Gene. 2015;571(1):1-8. https://doi.org/10.1016/j.gene.2015.07.071.

Article  CAS  PubMed  PubMed Central